State Street Corp Bausch Health Companies Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $3.17 Million - $4.08 Million	-146,952 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $143,221 - $180,645	6,227 Added 4.42%	146,952 $4.06 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $83,057 - $99,709	3,317 Added 2.41%	140,725 $3.92 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $331,272 - $394,917	12,077 Added 9.64%	137,408 $4.03 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $441,632 - $710,497	-20,666 Reduced 14.16%	125,331 $3.98 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $104,062 - $143,552	6,797 Added 4.88%	145,997 $3.04 Million
Q3 2020 Nov 10, 2020	SELL	$14.88 - $20.13 $80,247 - $108,561	-5,393 Reduced 3.73%	139,200 $2.16 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $1.73 Million - $2.66 Million	129,704 Added 871.14%	144,593 $2.65 Million
Q1 2020 May 11, 2020	BUY	$12.98 - $30.25 $193,259 - $450,392	14,889 New	14,889 $231,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.83B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.